Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07582848 · ClinicalTrials.gov registry record · NA
BOND: Direct Breastfeeding to Enhance Maternal and Infant Health in Congenital Heart Disease
A NA study, sponsored by Carelon Research.
- Not yet
- Registry status
- NA
- Development phase
- 266
- Enrollment target
NCT07582848 is a NA study that has not yet begun recruiting, run by Carelon Research. The registered enrollment target is 266 participants.
The verdict
NCT07582848, a NA study, has not yet begun recruiting, sponsored by Carelon Research.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 266 participants
- Enrollment target
Study Summary
The primary objective of this study is to enhance the rates of direct breast feeding (DBF) among infants with congenital heart disease (CHD), and to gain insights into the implications of DBF on key metrics of child and parent well-being. A multicenter parallel cluster platform design will be employed. The intervention will be a multifaceted approach to enhance direct breastfeeding. Participating sites will be randomized into either intervention (strategies to enhance direct breastfeeding) or conventional care.
Interventions
- OTHER Breastfeeding clinical practice guideline (CPG) for congenital heart disease (CHD)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 266 participants |
| Start Date | 2026-04 |
| Est. Completion | 2030-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07582848
The ClinicalTrials.gov registry entry for NCT07582848 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 266 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Carelon Research, which has 50 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Breastfeeding clinical practice guideline (CPG) for congenital heart disease (CHD) is the first listed.
NCT07582848 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07582848 about?
NCT07582848 is a clinical study titled "BOND: Direct Breastfeeding to Enhance Maternal and Infant Health in Congenital Heart Disease". The primary objective of this study is to enhance the rates of direct breast feeding (DBF) among infants with congenital heart disease (CHD), and to gain insights into the implications of DBF on key metrics of child and parent well-being. A multicenter parallel cluster platform design will be employ...
What is the current status of trial NCT07582848?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 266 participants. The study started on 2026-04. Estimated completion is 2030-06.
What interventions are being tested in trial NCT07582848?
The interventions under investigation include: Breastfeeding clinical practice guideline (CPG) for congenital heart disease (CHD) (OTHER).
Who is sponsoring clinical trial NCT07582848?
This trial is sponsored by Carelon Research, which has 50 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.